IWMvsXBI
iShares Russell 2000 ETF against SPDR S&P Biotech ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IWM | XBI | |
|---|---|---|
| Expense ratio | 0.19% | 0.35% |
| Assets | $74.2B | $10.4B |
| Net flow, 1 month | −$1.3B | +$534M |
| Net flow, 1 year | −$4.1B | +$1.3B |
| Return, YTD | +12.5% | +23.4% |
| Return, 1 year | — | — |
| Avg daily volume | 25.1M | 9.7M |
| Holdings | 1941 | 135 |
| Listed | May 22, 2000 | Jan 31, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS